<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1282" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1282/" /><meta name="ncbi_pagename" content="Thiamine-Responsive Megaloblastic Anemia Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Thiamine-Responsive Megaloblastic Anemia Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Thiamine-Responsive Megaloblastic Anemia Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/05/04" /><meta name="citation_author" content="Kimihiko Oishi" /><meta name="citation_author" content="George A Diaz" /><meta name="citation_pmid" content="20301459" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1282/" /><meta name="citation_keywords" content="Rogers Syndrome" /><meta name="citation_keywords" content="TRMA" /><meta name="citation_keywords" content="Rogers Syndrome" /><meta name="citation_keywords" content="TRMA" /><meta name="citation_keywords" content="Thiamine transporter 1" /><meta name="citation_keywords" content="SLC19A2" /><meta name="citation_keywords" content="Thiamine-Responsive Megaloblastic Anemia Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Thiamine-Responsive Megaloblastic Anemia Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Kimihiko Oishi" /><meta name="DC.Contributor" content="George A Diaz" /><meta name="DC.Date" content="2017/05/04" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1282/" /><meta name="description" content="Thiamine-responsive megaloblastic anemia syndrome (TRMA) is characterized by megaloblastic anemia, progressive sensorineural hearing loss, and diabetes mellitus. Onset of megaloblastic anemia occurs between infancy and adolescence. The anemia is corrected with thiamine treatment, but the red cells remain macrocytic, and anemia can recur when treatment is withdrawn. Progressive sensorineural hearing loss has generally been early and can be detected in toddlers; hearing loss is irreversible and may not be prevented by thiamine treatment. The diabetes mellitus is non-type I in nature, with age of onset from infancy to adolescence. Thiamine treatment may delay onset of diabetes in some individuals." /><meta name="og:title" content="Thiamine-Responsive Megaloblastic Anemia Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Thiamine-responsive megaloblastic anemia syndrome (TRMA) is characterized by megaloblastic anemia, progressive sensorineural hearing loss, and diabetes mellitus. Onset of megaloblastic anemia occurs between infancy and adolescence. The anemia is corrected with thiamine treatment, but the red cells remain macrocytic, and anemia can recur when treatment is withdrawn. Progressive sensorineural hearing loss has generally been early and can be detected in toddlers; hearing loss is irreversible and may not be prevented by thiamine treatment. The diabetes mellitus is non-type I in nature, with age of onset from infancy to adolescence. Thiamine treatment may delay onset of diabetes in some individuals." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1282/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/trma/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1282/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89D240DFC81C010000000007D803B6.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1282_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1282_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/td/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gr_3ms/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1282_"><span class="title" itemprop="name">Thiamine-Responsive Megaloblastic Anemia Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Rogers Syndrome, TRMA</div><p class="contrib-group"><span itemprop="author">Kimihiko Oishi</span>, MD and <span itemprop="author">George A Diaz</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1282_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1282_ai__"><div class="contrib half_rhythm"><span itemprop="author">Kimihiko Oishi</span>, MD<div class="affiliation small">Departments of Pediatrics and Genetics and Genomic Sciences<br />Icahn School of Medicine at Mount Sinai<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.ianistnuom@ihsio.okihimik" class="oemail">gro.ianistnuom@ihsio.okihimik</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">George A Diaz</span>, MD, PhD<div class="affiliation small">Department of Genetics and Genomic Sciences<br />Icahn School of Medicine at Mount Sinai<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mssm@zaid.egroeg" class="oemail">ude.mssm@zaid.egroeg</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 24, 2003</span>; Last Update: <span itemprop="dateModified">May 4, 2017</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="trma.Summary" itemprop="description"><h2 id="_trma_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Thiamine-responsive megaloblastic anemia syndrome (TRMA) is characterized by megaloblastic anemia, progressive sensorineural hearing loss, and diabetes mellitus. Onset of megaloblastic anemia occurs between infancy and adolescence. The anemia is corrected with thiamine treatment, but the red cells remain macrocytic, and anemia can recur when treatment is withdrawn. Progressive sensorineural hearing loss has generally been early and can be detected in toddlers; hearing loss is irreversible and may not be prevented by thiamine treatment. The diabetes mellitus is non-type I in nature, with age of onset from infancy to adolescence. Thiamine treatment may delay onset of diabetes in some individuals.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of TRMA is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (with or without diabetes or hearing loss):</p><ul><li class="half_rhythm"><div>With megaloblastic anemia and normal vitamin B<sub>12</sub>/folic acid levels in whom there is a response to oral thiamine; and/or</div></li><li class="half_rhythm"><div>By identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SLC19A2</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li></ul></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Lifelong use of pharmacologic doses (50-100 mg/day) of oral thiamine (vitamin B<sub>1</sub>) in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals regardless of age. Red blood cell transfusion for severe anemia.</p><p><i>Prevention of secondary complications:</i> Complications secondary to poor glycemic control for diabetes or chronic anemia may occur. Ongoing management of the primary disease is essential.</p><p><i>Surveillance</i>: At least yearly monitoring of the efficacy of the oral thiamine therapy and of disease progression, including: hematologic tests (CBC, reticulocyte count); assessment for glucose intolerance (fasting serum glucose concentration, OGTT, urine analysis); and hearing, ophthalmologic, and cardiac evaluations.</p><p><i>Pregnancy management</i>: Good diabetic control prior to and during pregnancy is recommended.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>TRMA is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible for families in which the <i>SLC19A2</i> pathogenic variants have been identified in the affected family member.</p></div></div><div id="trma.Diagnosis"><h2 id="_trma_Diagnosis_">Diagnosis</h2><div id="trma.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Thiamine-responsive megaloblastic anemia syndrome (TRMA) <b>should be suspected in</b> individuals with the following triad of clinical features:</p><ul><li class="half_rhythm"><div><b>Megaloblastic anemia</b> occurring between infancy and adolescence:</div><ul><li class="half_rhythm"><div>Examination of the bone marrow reveals megaloblastic changes with erythroblasts often containing iron-filled mitochondria (ringed sideroblasts).</div></li><li class="half_rhythm"><div>Vitamin B<sub>12</sub>/folic acid levels are normal</div></li><li class="half_rhythm"><div>The anemia is corrected with pharmacologic doses of thiamine (vitamin B<sub>1</sub>) (50-100 mg/day). However, the red cells remain macrocytic, suggesting a persistent erythropoietic abnormality [<a class="bk_pop" href="#trma.REF.haworth.1982.549">Haworth et al 1982</a>, <a class="bk_pop" href="#trma.REF.neufeld.1997.1335">Neufeld et al 1997</a>]; anemia can recur when thiamine is withdrawn.</div></li><li class="half_rhythm"><div>Even without thiamine supplementation, serum thiamine concentrations are normal; there is no evidence of acidosis or aciduria.</div></li></ul></li><li class="half_rhythm"><div><b>Progressive sensorineural deafness.</b> Hearing loss is generally early and has been detected in toddlers. Whether hearing loss is <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> (prelingual) is unknown. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have signs of megaloblastic anemia and diabetes at an early age, but no hearing loss.</div></li><li class="half_rhythm"><div><b>Diabetes mellitus</b> that is non-type I in nature, with age of onset from infancy to adolescence. Insulin secretion is present but defective [<a class="bk_pop" href="#trma.REF.valerio.1998.38">Valerio et al 1998</a>].</div></li></ul></div><div id="trma.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of TRMA <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with megaloblastic anemia with normal vitamin B<sub>12</sub>/folic acid levels, with or without diabetes or hearing loss in whom there is a response to oral thiamine and/or identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SLC19A2</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1282/table/trma.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figtrmaTmoleculargenetictestingusedin" rid-ob="figobtrmaTmoleculargenetictestingusedin">Table 1</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SLC19A2</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SLC19A2</i> and other genes of interest (see <a href="#trma.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> varies by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="trma.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Thiamine-Responsive Megaloblastic Anemia Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1282/table/trma.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trma.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC19A2</i></td><td headers="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nearly 100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_trma.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very rare; observed in 1 family to date&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="trma.TF.1.1"><p class="no_margin">See <a href="/books/NBK1282/#trma.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="trma.TF.1.2"><p class="no_margin">See <a href="#trma.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="trma.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="trma.TF.1.4"><p class="no_margin">Nearly all individuals with the diagnostic phenotypic triad evaluated by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> have identifiable pathogenic variants in <i>SLC19A2</i>. To date, more than 40 families with 33 distinct pathogenic variants have been identified [<a class="bk_pop" href="#trma.REF.diaz.1999.309">Diaz et al 1999</a>, <a class="bk_pop" href="#trma.REF.raz.2000.37">Raz et al 2000</a>, <a class="bk_pop" href="#trma.REF.scharfe.2000.669">Scharfe et al 2000</a>, <a class="bk_pop" href="#trma.REF.gritli.2001.508">Gritli et al 2001</a>, <a class="bk_pop" href="#trma.REF.neufeld.2001.135">Neufeld et al 2001</a>, <a class="bk_pop" href="#trma.REF.ozdemir.2002.205">Ozdemir et al 2002</a>, <a class="bk_pop" href="#trma.REF.lagarde.2004.299">Lagarde et al 2004</a>, <a class="bk_pop" href="#trma.REF.ricketts.2006.99">Ricketts et al 2006</a>, <a class="bk_pop" href="#trma.REF.bergmann.2009.888">Bergmann et al 2009</a>, <a class="bk_pop" href="#trma.REF.onal.2009.301">Onal et al 2009</a>, <a class="bk_pop" href="#trma.REF.pichler.2012.1711">Pichler et al 2012</a>, <a class="bk_pop" href="#trma.REF.shawsmith.2012.314">Shaw-Smith et al 2012</a>, <a class="bk_pop" href="#trma.REF.yilmaz_agladioglu.2012.149">Yilmaz Agladioglu et al 2012</a>]. Homozygosity by descent has been the most common finding. Seven individuals from six families were compound heterozygotes with distinct pathogenic variants from each parent [<a class="bk_pop" href="#trma.REF.bergmann.2009.888">Bergmann et al 2009</a>, <a class="bk_pop" href="#trma.REF.pichler.2012.1711">Pichler et al 2012</a>, <a class="bk_pop" href="#trma.REF.shawsmith.2012.314">Shaw-Smith et al 2012</a>].</p></div></dd><dt>5. </dt><dd><div id="trma.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="trma.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#trma.REF.beshlawi.2014.528">Beshlawi et al [2014]</a></p></div></dd></dl></div></div></div></div></div><div id="trma.Clinical_Characteristics"><h2 id="_trma_Clinical_Characteristics_">Clinical Characteristics</h2><div id="trma.Clinical_Description"><h3>Clinical Description</h3><p>Thiamine-responsive megaloblastic anemia syndrome (TRMA) is characterized by megaloblastic anemia, progressive sensorineural hearing loss, and diabetes mellitus.</p><ul><li class="half_rhythm"><div>The earliest findings of significant bone marrow problems (see <a href="#trma.Suggestive_Findings">Suggestive Findings</a>) have been in the first year of life and the latest in teenage years.</div><ul><li class="half_rhythm"><div>Peripheral blood count shows a pattern of macrocytic anemia with low hemoglobin and high mean corpuscular volume (MCV) in the absence of deficiencies of folate or vitamin B<sub>12</sub>.</div></li><li class="half_rhythm"><div>Bone marrow shows dysplastic hematopoiesis with numerous megaloblasts.</div></li></ul></li><li class="half_rhythm"><div>Hearing defects may be present at an early age and in some families may even be present at birth [<a class="bk_pop" href="#trma.REF.setoodeh.2013.295">Setoodeh et al 2013</a>]. Progressive sensorineural hearing loss is irreversible and may not be prevented by thiamine treatment. The basis of the sensorineural deafness is obscure; it is not known if the deafness is caused by abnormalities of the cochlea or of the auditory nerve. However, animal studies suggest that selective inner hair cell loss in the cochlea could be the cause of hearing defects in TRMA [<a class="bk_pop" href="#trma.REF.liberman.2006.211">Liberman et al 2006</a>].</div></li><li class="half_rhythm"><div>Non-type I diabetes mellitus has appeared before school age in many (though not all) individuals with glycosuria and hyperglycemia. Diabetic ketoacidosis has been reported in a few cases [<a class="bk_pop" href="#trma.REF.kurto_lu.2008.393">Kurto&#x0011f;lu et al 2008</a>, <a class="bk_pop" href="#trma.REF.pomaha_ov_.2017.844">Pomaha&#x0010d;ov&#x000e1; et al 2017</a>]. Initially, patients respond to oral hypoglycemic agents but most become insulin dependent in the long term.</div></li></ul><p>In addition to the triad of clinical features that characterize TRMA, other findings have been observed, each in only a subset of individuals:</p><ul><li class="half_rhythm"><div>Optic atrophy, when commented on in case reports, appears common. Abnormal appearance of the retina and functional retinal dystrophy have been reported [<a class="bk_pop" href="#trma.REF.meire.2000.243">Meire et al 2000</a>, <a class="bk_pop" href="#trma.REF.kipioti.2003.105">Kipioti et al 2003</a>, <a class="bk_pop" href="#trma.REF.lagarde.2004.299">Lagarde et al 2004</a>]. The kindred reported as having DIDMOAD (<i>d</i>iabetes <i>i</i>nsipidus, <i>d</i>iabetes <i>m</i>ellitus, <i>o</i>ptic <i>a</i>trophy, and <i>d</i>eafness) by <a class="bk_pop" href="#trma.REF.borgnapignatti.1989.405">Borgna-Pignatti et al [1989]</a> has in retrospect been shown by genetic analysis to have TRMA; optic atrophy was not known to be a finding of TRMA at the time (see <a href="#trma.Differential_Diagnosis">Differential Diagnosis</a>).</div></li><li class="half_rhythm"><div>Cardiovascular abnormalities including sudden death, stroke, high-output heart failure, paroxysmal atrial tachycardia, atrial standstill, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects such as atrial septal defect or ventricular septal defect have been reported in 27% of individuals with TRMA [<a class="bk_pop" href="#trma.REF.villa.2000.947">Villa et al 2000</a>, <a class="bk_pop" href="#trma.REF.lorber.2003.476">Lorber et al 2003</a>, <a class="bk_pop" href="#trma.REF.lagarde.2004.299">Lagarde et al 2004</a>, <a class="bk_pop" href="#trma.REF.aycan.2011.144">Aycan et al 2011</a>, <a class="bk_pop" href="#trma.REF.shawsmith.2012.314">Shaw-Smith et al 2012</a>].</div></li><li class="half_rhythm"><div>Significant neurologic deficit including stroke and focal or generalized epilepsy has been reported during early childhood in 27% of individuals with TRMA [<a class="bk_pop" href="#trma.REF.shawsmith.2012.314">Shaw-Smith et al 2012</a>].</div></li></ul></div><div id="trma.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation has been discerned.</p></div><div id="trma.Nomenclature"><h3>Nomenclature</h3><p>The synonym "Rogers syndrome" derives from the first report of the disease in a child with diabetes mellitus, sensorineural deafness, and megaloblastic anemia who responded to thiamine (vitamin B<sub>1</sub>) treatment.</p><p>One case report suggests "thiamine-responsive myelodysplasia" as an alternative name for the syndrome [<a class="bk_pop" href="#trma.REF.bazarbachi.1998.1098">Bazarbachi et al 1998</a>].</p></div><div id="trma.Prevalence"><h3>Prevalence</h3><p>Approximately 50 pedigrees are known.</p><p>TRMA is exceedingly rare outside of <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> families or isolated populations. Cases have been observed in various ethnicities including Israeli Arab and Lebanese populations, an Alaskan kindred of native and ethnic Russian descent, and kindreds from Brazil, Japan, Oman, Tunisia, Italy (Venetian and other), Iran, India, and Pakistan, as well as Kashmiri families in Great Britain, ethnic Kurds, persons of northern European heritage, and African Americans [<a class="bk_pop" href="#trma.REF.raz.2000.37">Raz et al 2000</a>, <a class="bk_pop" href="#trma.REF.neufeld.2001.135">Neufeld et al 2001</a>, <a class="bk_pop" href="#trma.REF.lagarde.2004.299">Lagarde et al 2004</a>, <a class="bk_pop" href="#trma.REF.bergmann.2009.888">Bergmann et al 2009</a>, <a class="bk_pop" href="#trma.REF.pichler.2012.1711">Pichler et al 2012</a>, <a class="bk_pop" href="#trma.REF.shawsmith.2012.314">Shaw-Smith et al 2012</a>, <a class="bk_pop" href="#trma.REF.yilmaz_agladioglu.2012.149">Yilmaz Agladioglu et al 2012</a>].</p></div></div><div id="trma.Genetically_Related_Allelic_Disorde"><h2 id="_trma_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>SLC19A2</i>.</p></div><div id="trma.Differential_Diagnosis"><h2 id="_trma_Differential_Diagnosis_">Differential Diagnosis</h2><p>The combination of megaloblastic red cell changes and ringed sideroblasts in individuals with thiamine-responsive megaloblastic anemia syndrome (TRMA) is unique among anemias influenced by metabolic or nutritional causes. Among acquired anemias, this combination is most suggestive of myelodysplastic syndromes in which megaloblastosis and sideroblasts are often noted. TRMA should not be confused with myelodysplastic disorders of premalignant potential.</p><p>Phenotypic overlap exists between TRMA and <a href="/books/n/gene/wfs/">Wolfram syndrome</a>, or DIDMOAD (<i>d</i>iabetes <i>i</i>nsipidus, <i>d</i>iabetes <i>m</i>ellitus, <i>o</i>ptic <i>a</i>trophy, and <i>d</i>eafness), including diabetes mellitus, optic atrophy, and deafness. Notably missing in Wolfram syndrome are megaloblastic anemia and thiamine responsiveness. Wolfram syndrome is caused by pathogenic variants in <i>WFS1</i>. The encoded protein is a novel transmembrane glycoprotein of 100 kd located in the endoplasmic reticulum, where it is thought to play a role in membrane trafficking, protein processing, or regulation of calcium homeostasis.</p><p>The combination of diabetes mellitus and deafness calls to mind mitochondrial disorders [<a class="bk_pop" href="#trma.REF.fischelghodsian.1999.261">Fischel-Ghodsian 1999</a>], but the macrocytic anemia, megaloblastic bone marrow, and response to thiamine distinguish TRMA from these disorders (see <a href="/books/n/gene/mt-overview/">Mitochondrial Disease Overview</a>). Inheritance in TRMA is unequivocally <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, which sets it apart from disorders with apparent maternal transmission and <a class="def" href="/books/n/gene/glossary/def-item/mitochondrial-inheritance/">mitochondrial inheritance</a>.</p></div><div id="trma.Management"><h2 id="_trma_Management_">Management</h2><div id="trma.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with thiamine-responsive megaloblastic anemia syndrome (TRMA), the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Peripheral blood count and bone marrow analysis for evidence of megaloblastic anemia</div></li><li class="half_rhythm"><div>Serum folate concentration, serum vitamin B<sub>12</sub> concentration, and serum iron studies to exclude other entities</div></li><li class="half_rhythm"><div>Hearing test</div></li><li class="half_rhythm"><div>Fasting serum glucose concentration, oral glucose tolerance test (OGTT), and urinalysis to diagnose diabetes mellitus</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Cardiac evaluation, including echocardiography</div></li><li class="half_rhythm"><div>Neuroimaging including brain MRI when clinically indicated</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="trma.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="trma.Thiamine"><h4>Thiamine</h4><p>Management focuses on lifelong use of pharmacologic doses (50-100 mg/day) of oral thiamine (vitamin B<sub>1</sub>) in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals regardless of age.</p><p>High-dose thiamine supplementation:</p><ul><li class="half_rhythm"><div>Invariably improves the hematologic picture;</div></li><li class="half_rhythm"><div>Did not prevent the development of hearing loss in infants with TRMA in some studies [<a class="bk_pop" href="#trma.REF.borgnapignatti.2009.295">Borgna-Pignatti et al 2009</a>, <a class="bk_pop" href="#trma.REF.ak_n.2011.36">Ak&#x00131;n et al 2011</a>]. The efficacy of high-dose thiamine in improving hearing or delaying hearing loss has been difficult to study and remains unclear.</div></li><li class="half_rhythm"><div>May delay onset of diabetes mellitus, and may ameliorate diabetes mellitus in the short term and perhaps even for decades [<a class="bk_pop" href="#trma.REF.valerio.1998.38">Valerio et al 1998</a>]. Insulin requirements are reduced with thiamine therapy in some cases [<a class="bk_pop" href="#trma.REF.neufeld.1997.1335">Neufeld et al 1997</a>].</div></li><li class="half_rhythm"><div>Has not been evaluated as a treatment for optic atrophy, cardiovascular abnormalities, or neurologic abnormalities associated with TRMA.</div></li></ul></div><div id="trma.Additional_Treatment"><h4>Additional Treatment</h4><p>Red blood cell transfusion for severe anemia is indicated.</p><p>See <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a> for treatment strategies for hearing loss. Treatment has included cochlear implant [<a class="bk_pop" href="#trma.REF.hagr.2014.78">Hagr 2014</a>].</p><p>Diabetes, cardiovascular abnormalities, and neurologic disorders should be treated in the standard manner.</p></div></div><div id="trma.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>See <a href="#trma.Treatment_of_Manifestations">Treatment of Manifestations</a>.</p></div><div id="trma.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Complications secondary to poor glycemic control for diabetes or chronic anemia may occur. Ongoing management of the primary disease is essential.</p></div><div id="trma.Surveillance"><h3>Surveillance</h3><p>The following are recommended at least yearly to monitor the efficacy of the oral thiamine therapy as well as disease progression:</p><ul><li class="half_rhythm"><div>Hematologic tests (CBC, reticulocyte count)</div></li><li class="half_rhythm"><div>Hearing test</div></li><li class="half_rhythm"><div>Assessment for glucose intolerance (fasting serum glucose concentration, OGTT, urinalysis)</div></li><li class="half_rhythm"><div>Ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Cardiac evaluation</div></li><li class="half_rhythm"><div>Neurologic evaluation</div></li></ul></div><div id="trma.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the <i>SLC19A2</i> pathogenic variants in the family in order to identify those who would benefit from prompt initiation of treatment and preventive measures.</p><p>Supplementation with pharmacologic doses of thiamine (vitamin B<sub>1</sub>) (25-75 mg/day compared to US RDA of 1.5 mg/day) is recommended as early as possible for at-risk sibs until their genetic status can be determined.</p><p>See <a href="#trma.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="trma.Pregnancy_Management"><h3>Pregnancy Management</h3><p>While there are no published studies evaluating pregnancy outcome in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women, good diabetic control prior to and during pregnancy is recommended.</p></div><div id="trma.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="trma.Genetic_Counseling"><h2 id="_trma_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="trma.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Thiamine-responsive megaloblastic anemia syndrome (TRMA) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="trma.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>SLC19A2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with TRMA are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SLC19A2</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>SLC19A2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="trma.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>SLC19A2</i> pathogenic variants in the family.</p></div><div id="trma.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#trma.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="trma.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SLC19A2</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for TRMA are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="trma.Resources"><h2 id="_trma_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Alexander Graham Bell Association for the Deaf and Hard of Hearing</b></div><div>3417 Volta Place Northwest</div><div>Washington DC 20007</div><div><b>Phone:</b> 866-337-5220 (toll-free); 202-337-5220; 202-337-5221 (TTY)</div><div><b>Fax:</b> 202-337-8314</div><div><b>Email:</b> info@agbell.org</div><div><a href="http://www.agbell.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Listening and Spoken Language Knowledge Center</a></div></li><li class="half_rhythm"><div><b>American Diabetes Association (ADA)</b></div><div><b>Phone:</b> 1-800-DIABETES (800-342-2383)</div><div><b>Email:</b> AskADA@diabetes.org</div><div><a href="http://www.diabetes.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.diabetes.org</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>BabyHearing.org</b></div><div><i>This site, developed with support from the National Institute on Deafness and Other Communication Disorders, provides information about newborn hearing screening and hearing loss.</i></div><div><a href="http://www.babyhearing.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.babyhearing.org</a></div></li><li class="half_rhythm"><div><b>National Association of the Deaf (NAD)</b></div><div>8630 Fenton Street</div><div>Suite 820</div><div>Silver Spring MD 20910</div><div><b>Phone:</b> 301-587-1788; 301-587-1789 (TTY)</div><div><b>Fax:</b> 301-587-1791</div><div><b>Email:</b> nad.info@nad.org</div><div><a href="http://www.nad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nad.org</a></div></li></ul></div><div id="trma.Molecular_Genetics"><h2 id="_trma_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="trma.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Thiamine-Responsive Megaloblastic Anemia Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1282/table/trma.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trma.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_trma.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_trma.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_trma.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_trma.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_trma.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_trma.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_trma.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10560" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SLC19A2</i></a></td><td headers="hd_b_trma.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10560" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q24<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_trma.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O60779" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Thiamine transporter 1</a></td><td headers="hd_b_trma.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SLC19A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC19A2 database</a></td><td headers="hd_b_trma.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC19A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC19A2</a></td><td headers="hd_b_trma.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SLC19A2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC19A2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="trma.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="trma.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Thiamine-Responsive Megaloblastic Anemia Syndrome (<a href="/omim/249270,603941" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1282/table/trma.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trma.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/249270" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">249270</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603941" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603941</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 2; SLC19A2</td></tr></tbody></table></div></div><div id="trma.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Defect of a high-affinity thiamine transporter, SLC19A2, causes TRMA; however, it is still unclear how the absence of <i>SLC19A2</i> expression results in the seemingly divergent disorders of megaloblastic anemia, diabetes mellitus, and deafness. Biochemical studies on fibroblasts or erythrocytes from individuals with TRMA showed that absence of the high-affinity component of thiamine transport results in low intracellular thiamine concentrations [<a class="bk_pop" href="#trma.REF.rindi.1992.231">Rindi et al 1992</a>, <a class="bk_pop" href="#trma.REF.stagg.1999.723">Stagg et al 1999</a>]. Defective RNA ribose synthesis caused by intracellular thiamine deficiency is thought to be the cause of megaloblastic changes in TRMA [<a class="bk_pop" href="#trma.REF.boros.2003.3556">Boros et al 2003</a>]. <i>Slc19a2</i> knockout mouse models have been developed [<a class="bk_pop" href="#trma.REF.oishi.2002.2951">Oishi et al 2002</a>, <a class="bk_pop" href="#trma.REF.fleming.2003.234">Fleming et al 2003</a>]; the animal models manifest megaloblastic changes, diabetes mellitus, and sensorineural deafness (the main features of TRMA) when dietary thiamine levels are decreased [<a class="bk_pop" href="#trma.REF.oishi.2002.2951">Oishi et al 2002</a>]. While the mechanism of megaloblastic changes is still to be elucidated, these models showed defects in insulin secretion and selective loss of inner hair cells in cochlea [<a class="bk_pop" href="#trma.REF.oishi.2002.2951">Oishi et al 2002</a>, <a class="bk_pop" href="#trma.REF.liberman.2006.211">Liberman et al 2006</a>].</p><p>Questions regarding TRMA disease pathogenesis that still require explanation include why individuals with TRMA do not have manifestations seen in dietary thiamine deficiency [<a class="bk_pop" href="#trma.REF.mandel.1984.836">Mandel et al 1984</a>, <a class="bk_pop" href="#trma.REF.poggi.1984.153">Poggi et al 1984</a>, <a class="bk_pop" href="#trma.REF.abboud.1985.537">Abboud et al 1985</a>] and why the findings in TRMA are organ specific.</p><p>Studies showed that a second high-affinity thiamine transporter, encoded by <i>SLC19A3</i>, has major roles in intestinal thiamine uptake in mouse, accounting for the absence of overt thiamine deficiency in persons with TRMA [<a class="bk_pop" href="#trma.REF.reidling.2010.1802">Reidling et al 2010</a>]. In support of this, two Japanese brothers with a Wernicke's-like encephalopathy were reported to have <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic variants in <i>SLC19A3</i> [<a class="bk_pop" href="#trma.REF.kono.2009.1792">Kono et al 2009</a>]. In addition, the difference in distribution of expression of the two thiamine transporters is critical in TRMA: in pancreatic endocrine cells, the expression of <i>SLC19A2</i> is much higher than that of <i>SLC19A3</i> and TRMA-associated <i>SLC19A2</i> mutated alleles disrupt thiamine uptake significantly [<a class="bk_pop" href="#trma.REF.mee.2009.g197">Mee et al 2009</a>]. Similarly, it is hypothesized that in TRMA, the other affected tissues (namely, bone marrow and cochlea) do not express or minimally express <i>SLC19A3</i> [<a class="bk_pop" href="#trma.REF.eudy.2000.581">Eudy et al 2000</a>, <a class="bk_pop" href="#trma.REF.rajgopal.2001.175">Rajgopal et al 2001</a>].</p><p><b>Gene structure.</b>
<i>SLC19A2</i> spans approximately 22.5 kb and has six exons with a 237-bp 5' UTR and a 1,620-bp 3' UTR [<a class="bk_pop" href="#trma.REF.diaz.1999.309">Diaz et al 1999</a>, <a class="bk_pop" href="#trma.REF.dutta.1999.31925">Dutta et al 1999</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1282/#trma.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<i>SLC19A2</i> pathogenic variants are distributed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> with no apparent clustering or mutation hot spots. The majority of <i>SLC19A2</i> pathogenic variants known to date are predicted to be <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> for protein because of pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or frameshift variants and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants which would likely severely disrupt the folding and membrane targeting of the transporter. Additionally, some <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants and small <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> variants have been reported. Consistently, <a class="bk_pop" href="#trma.REF.balamurugan.2002.g37">Balamurugan &#x00026; Said [2002]</a> showed that introducing several of these pathogenic variants into transfected HeLa cells resulted in impaired thiamine uptake.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The 497-amino acid protein, the high-affinity thiamine transporter 1, is predicted to have 12 transmembrane domains.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants result in either a truncated protein from a premature stop codon or aberrantly folded protein caused by <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in transmembrane domains.</p></div></div><div id="trma.References"><h2 id="_trma_References_">References</h2><div id="trma.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="trma.REF.abboud.1985.537">Abboud MR, Alexander D, Najjar SS. Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. <span><span class="ref-journal">J Pediatr. </span>1985;<span class="ref-vol">107</span>:537–41.</span> [<a href="/pubmed/4045602" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4045602</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.ak_n.2011.36">Ak&#x00131;n L, Kurto&#x0011f;lu S, Kendirci M, Ak&#x00131;n MA, Karak&#x000fc;k&#x000e7;&#x000fc; M. Does early treatment prevent deafness in thiamine-responsive megaloblastic anaemia syndrome? <span><span class="ref-journal">J Clin Res Pediatr Endocrinol. </span>2011;<span class="ref-vol">3</span>:36–9.</span> [<a href="/pmc/articles/PMC3065315/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3065315</span></a>] [<a href="/pubmed/21448333" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21448333</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.aycan.2011.144">Aycan Z, Ba&#x0015f; VN, Cetinkaya S, A&#x0011f;ladio&#x0011f;lu SY, Kendirci HN, Senocak F. Thiamine-responsive megaloblastic anemia syndrome with atrial standstill: a case report. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2011;<span class="ref-vol">33</span>:144–7.</span> [<a href="/pubmed/21285901" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21285901</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.balamurugan.2002.g37">Balamurugan K, Said HM. Functional role of specific amino acid residues in human thiamine transporter SLC19A2: mutational analysis. <span><span class="ref-journal">Am J Physiol Gastrointest Liver Physiol. </span>2002;<span class="ref-vol">283</span>:G37–43.</span> [<a href="/pubmed/12065289" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12065289</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.bazarbachi.1998.1098">Bazarbachi A, Muakkit S, Ayas M, Taher A, Salem Z, Solh H, Haidar JH. Thiamine-responsive myelodysplasia. <span><span class="ref-journal">Br J Haematol. </span>1998;<span class="ref-vol">102</span>:1098–100.</span> [<a href="/pubmed/9734663" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9734663</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.bergmann.2009.888">Bergmann AK, Sahai I, Falcone JF, Fleming J, Bagg A, Borgna-Pignati C, Casey R, Fabris L, Hexner E, Mathews L, Ribeiro ML, Wierenga KJ, Neufeld EJ. Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update. <span><span class="ref-journal">J Pediatr. </span>2009;<span class="ref-vol">155</span>:888–92.e1.</span> [<a href="/pmc/articles/PMC2858590/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2858590</span></a>] [<a href="/pubmed/19643445" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19643445</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.borgnapignatti.2009.295">Borgna-Pignatti C, Azzalli M, Pedretti S. Thiamine-responsive megaloblastic anemia syndrome: long term follow-up. <span><span class="ref-journal">J Pediatr. </span>2009;<span class="ref-vol">155</span>:295–7.</span> [<a href="/pubmed/19619756" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19619756</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.borgnapignatti.1989.405">Borgna-Pignatti C, Marradi P, Pinelli L, Monetti N, Patrini C. Thiamine-responsive anemia in DIDMOAD syndrome. <span><span class="ref-journal">J Pediatr. </span>1989;<span class="ref-vol">114</span>:405–10.</span> [<a href="/pubmed/2537896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2537896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.beshlawi.2014.528">Beshlawi I, Al Zadjali S, Bashir W, Elshinawy M, Alrawas A, Wali Y. Thiamine responsive megaloblastic anemia: the puzzling phenotype. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2014;<span class="ref-vol">61</span>:528–31.</span> [<a href="/pubmed/24249281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24249281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.boros.2003.3556">Boros LG, Steinkamp MP, Fleming JC, Lee WN, Cascante M, Neufeld EJ. Defective RNA ribose synthesis in fibroblasts from patients with thiamine-responsive megaloblastic anemia (TRMA). <span><span class="ref-journal">Blood. </span>2003;<span class="ref-vol">102</span>:3556–61.</span> [<a href="/pubmed/12893755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12893755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.diaz.1999.309">Diaz GA, Banikazemi M, Oishi K, Desnick RJ, Gelb BD. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">22</span>:309–12.</span> [<a href="/pubmed/10391223" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10391223</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.dutta.1999.31925">Dutta B, Huang W, Molero M, Kekuda R, Leibach FH, Devoe LD, Ganapathy V, Prasad PD. Cloning of the human thiamine transporter, a member of the folate transporter family. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:31925–9.</span> [<a href="/pubmed/10542220" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10542220</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.eudy.2000.581">Eudy JD, Spiegelstein O, Barber RC, Wlodarczyk BJ, Talbot J, Finnell RH. Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. <span><span class="ref-journal">Mol Genet Metab. </span>2000;<span class="ref-vol">71</span>:581–90.</span> [<a href="/pubmed/11136550" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11136550</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.fischelghodsian.1999.261">Fischel-Ghodsian N. Mitochondrial deafness mutations reviewed. <span><span class="ref-journal">Hum Mutat. </span>1999;<span class="ref-vol">13</span>:261–70.</span> [<a href="/pubmed/10220138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10220138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.fleming.2003.234">Fleming JC, Tartaglini E, Kawatsuji R, Yao D, Fujiwara Y, Bednarski JJ, Fleming MD, Neufeld EJ. Male infertility and thiamine-dependent erythroid hypoplasia in mice lacking thiamine transporter Slc19a2. <span><span class="ref-journal">Mol Genet Metab. </span>2003;<span class="ref-vol">80</span>:234–41.</span> [<a href="/pubmed/14567973" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14567973</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.gritli.2001.508">Gritli S, Omar S, Tartaglini E, Guannouni S, Fleming JC, Steinkamp MP, Berul CI, Hafsia R, Jilani SB, Belhani A, Hamdi M, Neufeld EJ. A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome. <span><span class="ref-journal">Br J Haematol. </span>2001;<span class="ref-vol">113</span>:508–13.</span> [<a href="/pubmed/11380424" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11380424</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.hagr.2014.78">Hagr AA. Cochlear implant and thiamine-responsive megaloblastic anemia syndrome. <span><span class="ref-journal">Ann Saudi Med. </span>2014;<span class="ref-vol">34</span>:78–80.</span> [<a href="/pmc/articles/PMC6074931/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6074931</span></a>] [<a href="/pubmed/24658560" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24658560</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.haworth.1982.549">Haworth C, Evans DI, Mitra J, Wickramasinghe SN. Thiamine responsive anaemia: a study of two further cases. <span><span class="ref-journal">Br J Haematol. </span>1982;<span class="ref-vol">50</span>:549–61.</span> [<a href="/pubmed/6175336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6175336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.kipioti.2003.105">Kipioti A, George ND, Hoffbrand AV, Sheridan E. Cone-rod dystrophy in thiamine-responsive megaloblastic anemia. <span><span class="ref-journal">J Pediatr Ophthalmol Strabismus. </span>2003;<span class="ref-vol">40</span>:105–7.</span> [<a href="/pubmed/12691235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12691235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.kono.2009.1792">Kono S, Miyajima H, Yoshida K, Togawa A, Shirakawa K, Suzuki H. Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>:1792–4.</span> [<a href="/pubmed/19387023" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19387023</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.kurto_lu.2008.393">Kurto&#x0011f;lu S, Hatipoglu N, Keskin M, Kendirci M, Akcakus M. Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings. <span><span class="ref-journal">J Pediatr Endocrinol Metab. </span>2008;<span class="ref-vol">21</span>:393–7.</span> [<a href="/pubmed/18556972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18556972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.lagarde.2004.299">Lagarde WH, Underwood LE, Moats-Staats BM, Calikoglu AS. Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">125A</span>:299–305.</span> [<a href="/pubmed/14994241" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14994241</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.liberman.2006.211">Liberman MC, Tartaglini E, Fleming JC, Neufeld EJ. Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype. <span><span class="ref-journal">J Assoc Res Otolaryngol. </span>2006;<span class="ref-vol">7</span>:211–7.</span> [<a href="/pmc/articles/PMC1805778/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1805778</span></a>] [<a href="/pubmed/16642288" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16642288</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.lorber.2003.476">Lorber A, Gazit AZ, Khoury A, Schwartz Y, Mandel H. Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome. <span><span class="ref-journal">Pediatr Cardiol. </span>2003;<span class="ref-vol">24</span>:476–81.</span> [<a href="/pubmed/14627317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14627317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.mandel.1984.836">Mandel H, Berant M, Hazani A, Naveh Y. Thiamine-dependent beriberi in the "thiamine-responsive anemia syndrome.". <span><span class="ref-journal">N Engl J Med. </span>1984;<span class="ref-vol">311</span>:836–8.</span> [<a href="/pubmed/6472386" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6472386</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.mee.2009.g197">Mee L, Nabokina SM, Sekar VT, Subramanian VS, Maedler K, Said HM. Pancreatic beta cells and islets take up thiamin by a regulated carrier-mediated process: studies using mice and human pancreatic preparations. <span><span class="ref-journal">Am J Physiol Gastrointest Liver Physiol. </span>2009;<span class="ref-vol">297</span>:G197–206.</span> [<a href="/pmc/articles/PMC2711754/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2711754</span></a>] [<a href="/pubmed/19423748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19423748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.meire.2000.243">Meire FM, Van Genderen MM, Lemmens K, Ens-Dokkum MH. Thiamine-responsive megaloblastic anemia syndrome (TRMA) with cone-rod dystrophy. <span><span class="ref-journal">Ophthalmic Genet. </span>2000;<span class="ref-vol">21</span>:243–50.</span> [<a href="/pubmed/11135496" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11135496</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.neufeld.2001.135">Neufeld EJ, Fleming JC, Tartaglini E, Steinkamp MP. Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. <span><span class="ref-journal">Blood Cells Mol Dis. </span>2001;<span class="ref-vol">27</span>:135–8.</span> [<a href="/pubmed/11358373" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11358373</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.neufeld.1997.1335">Neufeld EJ, Mandel H, Raz T, Szargel R, Yandava CN, Stagg A, Faure S, Barrett T, Buist N, Cohen N. Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. <span><span class="ref-journal">Am J Hum Genet. </span>1997;<span class="ref-vol">61</span>:1335–41.</span> [<a href="/pmc/articles/PMC1716091/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1716091</span></a>] [<a href="/pubmed/9399900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9399900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.oishi.2002.2951">Oishi K, Hofmann S, Diaz GA, Brown T, Manwani D, Ng L, Young R, Vlassara H, Ioannou YA, Forrest D, Gelb BD. Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice. <span><span class="ref-journal">Hum Mol Genet. </span>2002;<span class="ref-vol">11</span>:2951–60.</span> [<a href="/pubmed/12393806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12393806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.onal.2009.301">Onal H, Bari&#x0015f; S, Ozdil M, Ye&#x0015f;il G, Altun G, Ozyilmaz I, Aydin A, Celkan T. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness. <span><span class="ref-journal">Turk J Pediatr. </span>2009;<span class="ref-vol">51</span>:301–4.</span> [<a href="/pubmed/19817279" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19817279</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.ozdemir.2002.205">Ozdemir MA, Akcakus M, Kurtoglu S, Gunes T, Torun YA. TRMA syndrome (thiamine-responsive megaloblastic anemia): a case report and review of the literature. <span><span class="ref-journal">Pediatr Diabetes. </span>2002;<span class="ref-vol">3</span>:205–9.</span> [<a href="/pubmed/15016149" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15016149</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.pichler.2012.1711">Pichler H, Zeitlhofer P, Dworzak MN, Diakos C, Haas OA, Kager L. Thiamine-responsive megaloblastic anemia (TRMA) in an Austrian boy with compound heterozygous SLC19A2 mutations. <span><span class="ref-journal">Eur J Pediatr. </span>2012;<span class="ref-vol">171</span>:1711–5.</span> [<a href="/pubmed/22576805" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22576805</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.poggi.1984.153">Poggi V, Longo G, DeVizia B, Andria G, Rindi G, Patrini C, Cassandro E. Thiamin-responsive megaloblastic anaemia: a disorder of thiamin transport? <span><span class="ref-journal">J Inherit Metab Dis. </span>1984;<span class="ref-vol">7</span> Suppl 2:153–4.</span> [<a href="/pubmed/6090807" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6090807</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.pomaha_ov_.2017.844">Pomaha&#x0010d;ov&#x000e1; R, Zamboryov&#x000e1; J, S&#x000fd;kora J, Paterov&#x000e1; P, Fikl&#x000ed;k K, Votava T, &#x0010c;ern&#x000e1; Z, Jehli&#x0010d;ka P, L&#x000e1;d V, &#x00160;ubrt I, Dort J, Dortov&#x000e1; E. First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T&#x0003e;G. <span><span class="ref-journal">Pediatr Diabetes. </span>2017;<span class="ref-vol">18</span>:844–7.</span> [<a href="/pubmed/28004468" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28004468</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.rajgopal.2001.175">Rajgopal A, Edmondnson A, Goldman ID, Zhao R. SLC19A3 encodes a second thiamine transporter ThTr2. <span><span class="ref-journal">Biochim Biophys Acta. </span>2001;<span class="ref-vol">1537</span>:175–8.</span> [<a href="/pubmed/11731220" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11731220</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.raz.2000.37">Raz T, Labay V, Baron D, Szargel R, Anbinder Y, Barrett T, Rabl W, Viana MB, Mandel H, Baruchel A, Cayuela JM, Cohen N. The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families. <span><span class="ref-journal">Hum Mutat. </span>2000;<span class="ref-vol">16</span>:37–42.</span> [<a href="/pubmed/10874303" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10874303</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.reidling.2010.1802">Reidling JC, Lambrecht N, Kassir M, Said HM. Impaired intestinal vitamin B(1) (thiamin) uptake in thiamin transporter-2-deficient mice. <span><span class="ref-journal">Gastroenterology. </span>2010;<span class="ref-vol">138</span>:1802–9.</span> [<a href="/pmc/articles/PMC4916904/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4916904</span></a>] [<a href="/pubmed/19879271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19879271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.ricketts.2006.99">Ricketts CJ, Minton JA, Samuel J, Ariyawansa I, Wales JK, Lo IF, Barrett TG. Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. <span><span class="ref-journal">Acta Paediatr. </span>2006;<span class="ref-vol">95</span>:99–104.</span> [<a href="/pubmed/16373304" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16373304</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.rindi.1992.231">Rindi G, Casirola D, Poggi V, De Vizia B, Patrini C, Laforenza U. Thiamine transport by erythrocytes and ghosts in thiamine-responsive megaloblastic anaemia. <span><span class="ref-journal">J Inherit Metab Dis. </span>1992;<span class="ref-vol">15</span>:231–42.</span> [<a href="/pubmed/1326679" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1326679</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.scharfe.2000.669">Scharfe C, Hauschild M, Klopstock T, Janssen AJ, Heidemann PH, Meitinger T, Jaksch M. A novel mutation in the thiamine responsive megaloblastic anaemia gene SLC19A2 in a patient with deficiency of respiratory chain complex I. <span><span class="ref-journal">J Med Genet. </span>2000;<span class="ref-vol">37</span>:669–73.</span> [<a href="/pmc/articles/PMC1734685/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734685</span></a>] [<a href="/pubmed/10978358" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10978358</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.setoodeh.2013.295">Setoodeh A, Haghighi A, Saleh-Gohari N, Ellard S, Haghighi A. Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia. <span><span class="ref-journal">Gene. </span>2013;<span class="ref-vol">519</span>:295–7.</span> [<a href="/pmc/articles/PMC3725413/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3725413</span></a>] [<a href="/pubmed/23454484" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23454484</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.shawsmith.2012.314">Shaw-Smith C, Flanagan SE, Patch AM, Grulich-Henn J, Habeb AM, Hussain K, Pomahacova R, Matyka K, Abdullah M, Hattersley AT, Ellard S. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia. <span><span class="ref-journal">Pediatr Diabetes. </span>2012;<span class="ref-vol">13</span>:314–21.</span> [<a href="/pubmed/22369132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22369132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.stagg.1999.723">Stagg AR, Fleming JC, Baker MA, Sakamoto M, Cohen N, Neufeld EJ. Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts. <span><span class="ref-journal">J Clin Invest. </span>1999;<span class="ref-vol">103</span>:723–9.</span> [<a href="/pmc/articles/PMC408117/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC408117</span></a>] [<a href="/pubmed/10074490" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10074490</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.valerio.1998.38">Valerio G, Franzese A, Poggi V, Tenore A. Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. <span><span class="ref-journal">Diabetes Care. </span>1998;<span class="ref-vol">21</span>:38–41.</span> [<a href="/pubmed/9538968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9538968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.villa.2000.947">Villa V, Rivellese A, Di Salle F, Iovine C, Poggi V, Capaldo B. Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2000;<span class="ref-vol">85</span>:947–9.</span> [<a href="/pubmed/10720020" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10720020</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trma.REF.yilmaz_agladioglu.2012.149">Yilmaz Agladioglu S, Aycan Z, Bas VN, Peltek Kendirci HN, Onder A. Thiamine-responsive megaloblastic anemia syndrome: a novel mutation. <span><span class="ref-journal">Genet Couns. </span>2012;<span class="ref-vol">23</span>:149–56.</span> [<a href="/pubmed/22876572" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22876572</span></a>]</div></li></ul></div></div><div id="trma.Chapter_Notes"><h2 id="_trma_Chapter_Notes_">Chapter Notes</h2><div id="trma.Author_History"><h3>Author History</h3><p>George A Diaz, MD, PhD (2006-present) <br />Judith C Fleming, PhD; Children's Hospital and Harvard Medical School (2003-2006) <br />Ellis J Neufeld, MD, PhD; Children's Hospital and Harvard Medical School (2003-2006) <br />Kimihiko Oishi, MD (2006-present)</p></div><div id="trma.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>4 May 2017 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 November 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 September 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 April 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 November 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available clinically for <i>SCL19A2</i></div></li><li class="half_rhythm"><div>22 June 2006 (ca) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 October 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>25 August 2003 (ejn) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1282</span><span class="label">PMID: <a href="/pubmed/20301459" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301459</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/td/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gr_3ms/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1282&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1282/?report=reader">PubReader</a></li><li><a href="/books/NBK1282/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1282" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1282" style="display:none" title="Cite this Page"><div class="bk_tt">Oishi K, Diaz GA. Thiamine-Responsive Megaloblastic Anemia Syndrome. 2003 Oct 24 [Updated 2017 May 4]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1282/pdf/Bookshelf_NBK1282.pdf">PDF version of this page</a> (429K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#trma.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#trma.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#trma.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#trma.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#trma.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#trma.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#trma.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#trma.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#trma.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#trma.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#trma.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10560[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC19A2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1471566" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1471566" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1471566" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1471566" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28504500" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Infantile-onset thiamine responsive megaloblastic anemia syndrome with SLC19A2 mutation: a case report.</a><span class="source">[Arch Argent Pediatr. 2017]</span><div class="brieflinkpop offscreen_noflow">Infantile-onset thiamine responsive megaloblastic anemia syndrome with SLC19A2 mutation: a case report.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Katipoğlu N, Karapinar TH, Demir K, Aydin Köker S, Nalbantoğlu Ö, Ay Y, Korkmaz HA, Oymak Y, Yıldız M, Tunç S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Arch Argent Pediatr. 2017 Jun 1; 115(3):e153-e156. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29969779" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A Novel Mutation of SLC19A2 in a Chinese Zhuang Ethnic Family with Thiamine-Responsive Megaloblastic Anemia.</a><span class="source">[Cell Physiol Biochem. 2018]</span><div class="brieflinkpop offscreen_noflow">A Novel Mutation of SLC19A2 in a Chinese Zhuang Ethnic Family with Thiamine-Responsive Megaloblastic Anemia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Xian X, Liao L, Shu W, Li H, Qin Y, Yan J, Luo J, Lin FQ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cell Physiol Biochem. 2018; 47(5):1989-1997. Epub 2018 Jul 3.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30031565" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].</a><span class="source">[Rev Med Interne. 2019]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lu H, Lu H, Vaucher J, Tran C, Vollenweider P, Castioni J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rev Med Interne. 2019 Jan; 40(1):20-27. Epub 2018 Jul 19.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22876572" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Thiamine-responsive megaloblastic anemia syndrome: a novel mutation.</a><span class="source">[Genet Couns. 2012]</span><div class="brieflinkpop offscreen_noflow">Thiamine-responsive megaloblastic anemia syndrome: a novel mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yilmaz Agladioglu S, Aycan Z, Bas VN, Peltek Kendirci HN, Onder A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Genet Couns. 2012; 23(2):149-56. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301750" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WFS1</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WFS1</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tranebjærg L, Barrett T, Rendtorff ND. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301459" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301459" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc917275f66d18aa9a1566">Thiamine-Responsive Megaloblastic Anemia Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Thiamine-Responsive Megaloblastic Anemia Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:16:34-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89D240DFC81C010000000007D803B6&amp;ncbi_session=CE89D240DFC91711_2008SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1282%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1282&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1282/&amp;ncbi_pagename=Thiamine-Responsive Megaloblastic Anemia Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89D240DFC91711_2008SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>